Autres langues OmniAb, Inc.

Actions

OABI

US68218J1034

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 16/07/2024			Varia. 5j.	Varia. 1 janv.
4,74 ^USD	+2,82 %		+17,33 %	-23,18 %

01/07	OmniAb, Inc. annonce des changements au sein de son conseil d'administration	CI
29/05	Un initié d'Omniab a acheté des actions pour une valeur de 1 059 840 $, selon un récent dépôt auprès de la SEC	MT

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

OmniAb, Inc. Announces Board Changes	01/07
OmniAb, Inc.(NasdaqGM:OABI) added to Russell Microcap Growth Index	01/07
OmniAb, Inc.(NasdaqGM:OABI) added to Russell 2500 Growth Index	01/07
OmniAb, Inc.(NasdaqGM:OABI) added to Russell Small Cap Comp Growth Index	01/07
OmniAb, Inc.(NasdaqGM:OABI) added to Russell 3000E Growth Index	01/07
OmniAb, Inc.(NasdaqGM:OABI) added to Russell 3000 Growth Index	01/07
OmniAb, Inc.(NasdaqGM:OABI) added to Russell 2000 Growth Index	01/07
OmniAb : Submission of Matters to a Vote of Security Holders Form 8 K	21/06
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology	03/06
Omniab Insider Bought Shares Worth $1,059,840, According to a Recent SEC Filing	29/05
OmniAb to Participate in the Jefferies Global Healthcare Conference	20/05
OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit	15/05
OmniAb : May 2024 Corporate Overview	10/05
Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M	09/05
OmniAb, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights	09/05
OmniAb to Participate in Five Investor Conferences in May	01/05
OmniAb to Report First Quarter 2024 Financial Results on May 9	22/04
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate Biotherapeutics	16/04
OmniAb : March 2024 Corporate Overview	26/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues OmniAb, Inc.

Actions

OABI

US68218J1034

Autres langues

Filtres